You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
19 October 2026 - Pharmaceutical research and development company AbbVie (NYSE: ABBV) reported on Monday that its investigational dual-targeting therapy ABBV-466 achieved higher endoscopic remission rates than either anti-IL-23 or anti-α4β...
19 October 2026 - Japan-based biopharmaceutical company Takeda (TSE: 4502) (NYSE: TAK) announced on Monday that positive Phase IV VERDICT trial results show that treating adults with moderate to severe ulcerative colitis with ENTYVIO (vedolizumab) to...
19 October 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) on Monday reported a confirmed overall response rate of 61% for its investigational antibody-drug conjugate risvutatug rezetecan (Ris-Rez) at the 8 mg/kg dose in a Phase Ib tr...
19 October 2026 - Vivacta Biotechnology (Shanghai) Co Ltd (Vivacta Bio), a China-based company spun out of the in vivo CAR-T platform of Beijing Grit Biotherapeutics Co Ltd (Grit Bio), announced on Saturday that the U.S. Food and Drug Administration ...
16 October 2026 - Biotechnology company Omeros Corporation (Nasdaq:OMER) announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) maintained its negative opinion on the marketing authorisatio...
16 October 2026 - Swedish medical device company VibroSense Dynamics AB (Spotlight Stock Market: VSD B), which develops tools for diagnosing nerve damage in the hands and feet, said on Friday it has received regulatory approval in Thailand for VibroS...